The Luxembourg Institute of Health (LIH) has never been better positioned to become a leader in patient-based research in Luxembourg and Europe. In light of its new strategy, the LIH is pleased to announce the change in name for the Department of Oncology, and for the Department of Population Health to reflect their strategic transversal, translational research programs.

Hannah Wurzer, Postdoctoral Fellow at the Luxembourg Institute of Health, was conferred the Excellent Thesis Award for doctoral graduates who demonstrated excellence, originality and depth of knowledge in their thesis.

The Luxembourg Institute of Health (LIH) and Advanced Biological Laboratories (ABL) are joining forces to predict immune protection against COVID-19 and support long-term vaccination strategies. To this end, the two laboratories have signed a license agreement and a collaboration agreement to provide two in vitro diagnostic solutions to measure neutralizing antibody levels.

EATRIS Luxembourg Stakeholder meeting

Prof. Dr. Stefan Fröhling, Managing Director of the National Center for Tumor Diseases Heidelberg and the head of the division of Translational Medical Oncology of the German Cancer Consortium DKFZ, is a central character to the Precision Oncology programme in his Institute, focusing on research that aims to provide as many patients as possible with individually tailored cancer treatments. In occasion of his visit as a guest speaker for the Lecture Series Cancer Research, the LIH took the opportunity to ask Prof. Dr. Fröhling a few questions about his extensive experience in the field of cancer research.

To be part of the Tumor Stroma Interactions research group (Heads: Dr E. Moussay and Dr Jérôme Paggetti)  within the Department of Cancer Research at the LIH